DSCI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DSCI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Derma Sciences's Average Total Inventories for the three months ended in Sep. 2016 was $16.34 Mil. Derma Sciences's Cost of Goods Sold for the three months ended in Sep. 2016 was $11.10 Mil. Hence, Derma Sciences's Days Inventory for the three months ended in Sep. 2016 was 134.28.
The historical rank and industry rank for Derma Sciences's Days Inventory or its related term are showing as below:
Derma Sciences's Days Inventory declined from Sep. 2015 (155.85) to Sep. 2016 (134.28).
Inventory Turnover measures how fast the company turns over its inventory within a year. Derma Sciences's Inventory Turnover for the three months ended in Sep. 2016 was 0.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Derma Sciences's Inventory-to-Revenue for the three months ended in Sep. 2016 was 0.75.
The historical data trend for Derma Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Derma Sciences Annual Data | |||||||||||||||||||||
Trend | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 95.05 | 92.97 | 109.32 | 101.24 | 119.83 |
Derma Sciences Quarterly Data | ||||||||||||||||||||
Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | |
Days Inventory | Get a 7-Day Free Trial | 155.85 | 83.00 | 153.04 | 129.67 | 134.28 |
For the Medical Instruments & Supplies subindustry, Derma Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Derma Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Derma Sciences's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Derma Sciences's Days Inventory for the fiscal year that ended in Dec. 2015 is calculated as
Days Inventory (A: Dec. 2015 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2014 ) | + | Total Inventories (A: Dec. 2015 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2015 ) | * | Days in Period |
= | ( (13.281 | + | 20.691) | / | 2 ) | / | 51.74 | * | 365 |
= | 16.986 | / | 51.74 | * | 365 | ||||
= | 119.83 |
Derma Sciences's Days Inventory for the quarter that ended in Sep. 2016 is calculated as:
Days Inventory (Q: Sep. 2016 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Jun. 2016 ) | + | Total Inventories (Q: Sep. 2016 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2016 ) | * | Days in Period |
= | ( (18.287 | + | 14.393) | / | 2 ) | / | 11.104 | * | 365 / 4 |
= | 16.34 | / | 11.104 | * | 365 / 4 | ||||
= | 134.28 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Derma Sciences (NAS:DSCI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Derma Sciences's Inventory Turnover for the three months ended in Sep. 2016 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 11.104 | / | 16.34 | |
= | 0.68 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Derma Sciences's Inventory to Revenue for the three months ended in Sep. 2016 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 16.34 | / | 21.81 | |
= | 0.75 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Derma Sciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Samuel E Navarro | director | C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044 |
Robert G Moussa | director | 1375 KINGS HIGHWAY EAST, FAIRFIELD CT 06824 |
Stephen T Wills | director, other: Executive Chairman | PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512 |
Amy S Paul | other: Former Director | C.R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 |
Bruce F Wesson | other: Former Director | 1827 PACIFIC ST BROOKLYN NY 11233 |
Peter Kolchinsky | other: Fmr 10% Owner - See Fn (1)-(5) | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Ra Capital Management, L.p. | other: Fmr 10% Owner - See Fn (1)-(5) | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Ra Capital Healthcare Fund Lp | other: Fmr 10% Owner - See Fn (1)-(5) | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
William C Martin | 10 percent owner | C/O RAGING CAPITAL MANAGEMENT, LLC, TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553 |
Raging Capital Master Fund, Ltd. | 10 percent owner | C/O OGIER FIDUCIARY SERVICES (CAYMAN), 89 NEXUS WAY, CAMANA BAY, GRAND CAYMAN E9 KY 1-9007 |
Raging Capital Management, Llc | 10 percent owner | TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553-0228 |
Raging Capital Fund (qp), Lp | other: See explanation of responses | TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08853 |
Raging Capital Fund, Lp | other: See explanation of responses | TEN PRINCETON AVENUE, ROCKY HILL NJ 08553 |
Lehman Brothers Holdings Inc | 10 percent owner | 1271 AVENUE OF THE AMERICAS, NEW YORK NY 10020 |
Galen Partners Iii L P | 10 percent owner | 610 FIFTH AVE 5TH FL NEW YORK NY 10020 |
From GuruFocus
By gurufocus 10qk • 11-12-2010
By gurufocus 10qk • 05-12-2010
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.